BlackRock Unconstrained Equity Fund Class R Shares (MREGX)
NASDAQ · Mutual Fund
· Delayed Price · Currency is USD
13.90
+0.32 (2.36%)
May 2, 2025, 4:00 PM EDT
-0.43% (1Y)
| Fund Assets | 280.48M |
| Expense Ratio | n/a |
| Min. Investment | $100 |
| Turnover | n/a |
| Dividend (ttm) | n/a |
| Dividend Yield | n/a |
| Dividend Growth | n/a |
| Payout Frequency | n/a |
| Ex-Dividend Date | n/a |
| Previous Close | 13.58 |
| YTD Return | -0.93% |
| 1-Year Return | -0.43% |
| 5-Year Return | 85.83% |
| 52-Week Low | n/a |
| 52-Week High | n/a |
| Beta (5Y) | n/a |
| Holdings | 31 |
| Inception Date | Mar 1, 2007 |
About MREGX
The BlackRock Unconstrained Equity Fund Class R Shares (MREGX) seeks to provide high total investment return. MREGX will, under normal circumstances, invest at least 80% of its net assets in equity securities by policy utilizing United States and foreign equity securities.
Category World Large-Stock Growth
Performance Rating Average
Risk Rating Average
Stock Exchange NASDAQ
Ticker Symbol MREGX
Index MSCI World NR USD
Performance
MREGX had a total return of -0.43% in the past year, including dividends. Since the fund's inception, the average annual return has been 6.51%.
Top 10 Holdings
59.29% of assets| Name | Symbol | Weight |
|---|---|---|
| Microsoft Corporation | MSFT | 9.12% |
| ASML Holding N.V. | ASML | 7.38% |
| Meta Platforms, Inc. | META | 6.35% |
| Novo Nordisk A/S | NOVO.B | 6.07% |
| S&P Global Inc. | SPGI | 5.85% |
| Alphabet Inc. | GOOG | 4.98% |
| Visa Inc. | V | 4.98% |
| Mastercard Incorporated | MA | 4.94% |
| Thermo Fisher Scientific Inc. | TMO | 4.89% |
| Masimo Corporation | MASI | 4.72% |